ST Pharm Co.,Ltd. (237690.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.7x

Market Cap

KRW 2.06T

MomentumView details →

1D Return

−2.17%

YTD Return

−15.10%

RSI (14)

45.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.7x

Market Cap

KRW 2.06T

RSI (14)

45.1

MomentumView details →

1D Return

−2.17%

YTD Return

−15.10%

ProfitabilityView details →

Gross Margin

38.81%

Net Margin

19.87%

EBITDA Margin

27.01%

ROE (TTM)

12.19%

ROA (TTM)

9.05%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

+29.59%

EPS YoY

+116.24%

FCF YoY

+1035.51%

Revenue CAGR 3Y

+9.97%

EPS CAGR 3Y

+41.41%

EBITDA YoY

+25.40%

EarningsView details →

EPS (Actual)

KRW 632.88

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

4.40%

Capital & dividendView details →

Debt/Equity

0.12x

Current Ratio

2.28x

Quick Ratio

1.28x

Div Yield

0.51%

Div Rate

KRW 500.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

386.33B

Net Income (TTM)

76.75B

Op. CF (TTM)

113.85B

Latest newsMore news →

No recent news for 237690.KQ.

Similar companies

Mezzion Pharma Co.,Ltd.140410.KQ Sam Chun Dang Pharm. Co., Ltd000250.KQ GC Biopharma Corp.006280.KS ABL Bio Inc.298380.KQ Komipharm International Co., Ltd.041960.KQ Hyundai Bioscience Co., Ltd.048410.KQ Find similar companies →

Latest newsMore news →

No recent news for 237690.KQ.